Ablative Therapy

Can Ablative Therapy Play a Role in Treating Residual Disease in Stage IV NSCLC?

The International Association for the Study of Lung Cancer (IASLC) shared a post on X:

“Can ablative therapy play a role in treating residual disease in stage IV NSCLC? On Lung Cancer Considered,
Stephen V Liu joins Mara Antonoff, Shankar Siva and David Carbone to discuss a complex case and evolving treatment strategies.

Listen now.”

Find more posts on OncoDaily.